IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Seigo Iwado

USPTO Granted Patents = 10

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Hiromachi, JP (1982 - 1993)
  • Tokyo, JP (1984 - 1993)

Company Filing History:

goldMedal10 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1982-1993

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5272174 - Hydroxy-ML-236B derivatives, their preparation and use (1993-12-21),
2. 5212322 - Macrolide compounds, their preparation and their use (1993-05-18),
3. 5153124 - Hydroxyl-ML-236B derivatives, their preparation and use (1992-10-06),
4. 5008191 - Macrolide compounds, their preparation and their use (1991-04-16),
5. 4990178 - Herbicide, its preparation and use (1991-02-05),
6. 4918054 - Antibiotics called `chloropolysporins B and C`, a process for their (1990-04-17),
7. 4897104 - Anhydride herbicides (1990-01-30),
8. 4557933 - Antibiotic called 'chloropolysporin', a process for its preparation, and (1985-12-10),
9. 4460765 - Enzyme inhibitor produced by cultivation of streptomyces microorganisms (1984-07-17),
10. 4323648 - Preparation of Monacolin K (1982-04-06),

Title: Seigo Iwado: Innovator in Cholesterol Biosynthesis Inhibition

Introduction

Seigo Iwado is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit cholesterol biosynthesis. With a total of 10 patents to his name, Iwado's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Iwado's latest patents include innovative derivatives of Hydroxy-ML-236B. These derivatives, which possess a hydroxy group at the 3'-position and optionally at the 6'-position, are prepared through the enzymatic hydroxylation of corresponding ML-236B compounds. The enzymes used in this process are produced by specific microorganisms, including various strains of Streptomyces and Amycolata. These derivatives are notable for their ability to inhibit cholesterol biosynthesis, making them valuable in the treatment of related health issues.

Another significant patent involves macrolide compounds that exhibit acaricidal, insecticidal, and anthelmintic activities. These compounds are characterized by a specific chemical formula that allows for their diverse applications in pest control and health management.

Career Highlights

Seigo Iwado is associated with Sankyo Company, Limited, where he has been instrumental in advancing research in biochemistry and pharmacology. His innovative approaches and dedication to scientific inquiry have positioned him as a key figure in his field.

Collaborations

Iwado has collaborated with notable colleagues, including Takao Okazaki and Tatsuo Haneishi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Seigo Iwado's contributions to the field of biochemistry, particularly in the development of cholesterol biosynthesis inhibitors, highlight his role as an influential inventor. His work continues to inspire advancements in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…